rs28730694

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001386501.1(MTOR):​c.-222C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00198 in 1,614,090 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 36 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 26 hom. )

Consequence

MTOR
NM_001386501.1 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.573

Publications

2 publications found
Variant links:
Genes affected
MTOR (HGNC:3942): (mechanistic target of rapamycin kinase) The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This kinase is a component of two distinct complexes, mTORC1, which controls protein synthesis, cell growth and proliferation, and mTORC2, which is a regulator of the actin cytoskeleton, and promotes cell survival and cell cycle progression. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. Inhibitors of mTOR are used in organ transplants as immunosuppressants, and are being evaluated for their therapeutic potential in SARS-CoV-2 infections. Mutations in this gene are associated with Smith-Kingsmore syndrome and somatic focal cortical dysplasia type II. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Aug 2020]
MTOR Gene-Disease associations (from GenCC):
  • macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 1-11248017-G-A is Benign according to our data. Variant chr1-11248017-G-A is described in ClinVar as Benign. ClinVar VariationId is 414908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0105 (1597/152234) while in subpopulation AFR AF = 0.0373 (1548/41534). AF 95% confidence interval is 0.0357. There are 36 homozygotes in GnomAd4. There are 746 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1597 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001386501.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTOR
NM_004958.4
MANE Select
c.918C>Tp.Phe306Phe
synonymous
Exon 7 of 58NP_004949.1
MTOR
NM_001386501.1
c.-222C>T
5_prime_UTR_premature_start_codon_gain
Exon 7 of 57NP_001373430.1
MTOR
NM_001386500.1
c.918C>Tp.Phe306Phe
synonymous
Exon 7 of 58NP_001373429.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTOR
ENST00000361445.9
TSL:1 MANE Select
c.918C>Tp.Phe306Phe
synonymous
Exon 7 of 58ENSP00000354558.4
MTOR
ENST00000934315.1
c.918C>Tp.Phe306Phe
synonymous
Exon 7 of 58ENSP00000604374.1
MTOR
ENST00000934312.1
c.918C>Tp.Phe306Phe
synonymous
Exon 7 of 58ENSP00000604371.1

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1588
AN:
152116
Hom.:
36
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0372
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00276
AC:
693
AN:
251022
AF XY:
0.00200
show subpopulations
Gnomad AFR exome
AF:
0.0383
Gnomad AMR exome
AF:
0.00159
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000705
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.00109
AC:
1600
AN:
1461856
Hom.:
26
Cov.:
32
AF XY:
0.000920
AC XY:
669
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.0395
AC:
1322
AN:
33480
American (AMR)
AF:
0.00170
AC:
76
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53390
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000306
AC:
34
AN:
1112006
Other (OTH)
AF:
0.00245
AC:
148
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
92
184
275
367
459
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0105
AC:
1597
AN:
152234
Hom.:
36
Cov.:
32
AF XY:
0.0100
AC XY:
746
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0373
AC:
1548
AN:
41534
American (AMR)
AF:
0.00242
AC:
37
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68016
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
71
142
213
284
355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00582
Hom.:
8
Bravo
AF:
0.0119
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
1.9
DANN
Benign
0.65
PhyloP100
-0.57
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28730694; hg19: chr1-11308074; API